About 1 700 reports

  • Cardiovascular disorders
  • 3.2 RISK FACTORS AND COMORBIDITIES

Nature Publishing Group, ##(##), pp. ##-##. doi: ##. ##/ oby. 2011. ##.

  • Health Services
  • Japan
  • United States
  • World
  • Forecast

CLEARPOINT ELECTRODE PLACEMENT DEVICE - SEVERE DEPRESSION CLEARPOINT ELECTRODE PLACEMENT DEVICE - SEVERE DEPRESSION PRODUCT OVERVIEW CLEARPOINT ELECTRODE PLACEMENT DEVICE - SEVERE DEPRESSION - PRODUCT STATUS Market Category Developed By Pipeline Territory Highest Stage of

  • Health Services
  • Injectable Delivery
  • Neurology
  • United States
  • MRI Interventions, Inc.

Acute Agitation and Aggression Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 ## Preface ##. ## Market Definition and Scope ##. ## Market Segmentation ##. ## Key Research Objectives ##. ## Research Highlights ## Assumptions and Acronyms ## Research Meth

  • Health Services
  • Therapy
  • APAC
  • World
  • Market Size
  • Jan 18, 2018: New nerve stimulation treatment helps ease sleep apnea

" The depression has gone away.

  • Health Services
  • Injectable Delivery
  • Pharmaceutical
  • United States
  • Illumina, Inc.
  • Diabetes almost doubles the risk of AD (OR = 2.33, 95% CI =1.35-4.02).

Depression Multiple studies have reported that a recent history of depression is associated with increased incidence of AD.

  • Health Services
  • Japan
  • United States
  • World
  • Forecast

H. (2014) ' ANXIETY AND DEPRESSION IN PARKINSON' S DISEASE', CURRENT TREATMENT OPTIONS IN NEUROLOGY, ##(##), P. ##.

  • Health Services
  • Injectable Delivery
  • Adamas Pharmaceuticals, Inc.
  • Impax Laboratories, Inc.
  • Kyowa Hakko Kirin Co., Ltd.

REV PRESS., ##(##), PP. ##-##.

  • Health Services
  • Demand
  • Forecast
  • Pfizer Inc.
  • Sanofi S.A.
  • Comorbidities

HEALTH SURV ENGL 2012, ##:##-##.

  • Dermatological Condition
  • Health Services
  • United States
  • Forecast
  • Pfizer Inc.

But around ##% of those with depression do not respond to treatments and are classified as having treatmentresistant depression.

  • Health Services
  • United Kingdom
  • Social Conditions
  • Abzena plc
  • AstraZeneca PLC
  • 5.2 GLOBAL TELEMEDICINE - GYNECOLOGY MARKET AND FORECAST
  • 12.9 INCREASING ACCEPTANCE OF TELEMEDICINE BY PATIENTS

Postpartum depression: Offering convenient access for women suffering from postpartum depression is an essential part of providing perinatal care as an OB/ GYN (Obstetriciangynecologists).

  • Health Services
  • World
  • Market Size
  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • 4 Appendix

Frontotemporal Degeneration, ##(##-##), pp. ##-##. doi: ##. ##/ ##. 2014. ##.

  • Dementia
  • Health Services
  • Japan
  • United States
  • Forecast
  • 7.1 OVERVIEW
  • 4.5 PROGNOSIS

It works for pain and depression.

  • Health Services
  • Forecast
  • Daiichi Sankyo Company
  • Depomed, Inc.
  • Pfizer Inc.
  • UNIVERSAL HEALTH SERVICES
  • NATIONAL HEALTH SERVICE

It also offers treatment for other mental illness such as stress, depression, anxiety, grief and mood disorders.

  • Health Services
  • Specialty Hospital
  • World
  • Acadia Healthcare Company, Inc.
  • Universal Health Services, Inc.
  • 4.1 BIBLIOGRAPHY

Conditions such as depression and anxiety have been identified as comorbidities in PD.

  • Health Services
  • Japan
  • United Kingdom
  • United States
  • Forecast
  • NEUROLOGY DEVICES
  • MARKET SEGMENTATION BY TYPE OF DEVICE

P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E |

  • Health Services
  • Injectable Delivery
  • World
  • Demand
  • Market Size

Neurology Market: A BCC Research Overview Chapter ## Introduction Study Goals and Objectives Reasons for Doing this Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst’s Credentials Chapter ## Summary and Highlights Chapter ## Market and Technology Background Neu

  • Health Services
  • Therapy
  • World
  • Market Shares
  • Market Size
  • Description
  • 5.2 RISK FACTORS AND COMORBIDITIES

THE MAIN TREATMENT-EMERGENT ADVERSE EVENTS (TEAES) SEEN IN THIS STUDY WERE ALOPECIA (##%), NAUSEA AND/ OR VOMITING (##%), WEIGHT GAIN (##%), TREMOR (##%), SOMNOLENCE (##%), AND DEPRESSION (##%).

  • Health Services
  • Injectable Delivery
  • Allergan plc
  • Amgen Inc.
  • Pfizer Inc.
  • Neurology Device Market Trends and Strategies
  • Neurology Devices Market Characteristics

TRANSCRANIAL DIRECT CURRENT STIMULATION (TDCS) ARE USED TO ADDRESS CHRONIC PAIN, SCHIZOPHRENIA AND DEPRESSION.

  • Health Services
  • World
  • B. Braun Melsungen AG
  • Becton Property Group
  • Medtronic, Inc.
  • Neuromodulation Market
  • LIVANOVA: COMPANY SNAPSHOT (2016)

The company provides VNS therapy systems, which help in treatment of epilepsy and depression.

  • Health Services
  • Injectable Delivery
  • North America
  • United States
  • Boston Scientific Corporation
  • China Central Nervous System Therapeutic Market Size, By Value, 2019-2024 (USD Billion)
  • GLOBAL CENTRAL NERVOUS SYSTEM THERAPEUTIC MARKET SIZE, BY TYPE, 2024 (IN %)

Less substitute. ##.

  • Health Services
  • World
  • AstraZeneca PLC
  • Biogen Idec Inc.
  • Eli Lilly & Co.

The details ##.

  • Health Services
  • Healthcare
  • Injectable Delivery
  • World
  • Market Size

For example, according to the National Alliance on Mental Illness (NAMI), when a senior has untreated depression as well as heart disease, the depression can negatively affect the outcome of the disease.

  • Health Services
  • Injectable Delivery
  • World
  • Forecast
  • Thermo Fisher Scientific, Inc.
  • 3.4.3 Central Nervous System
  • Central Nervous System Pipeline, Number of Products by Indication, Q3 2018

The drug claimed blockbuster status just one year after its launch.

  • Health Services
  • Pharmaceutical
  • Therapy
  • Company
  • Market Size
  • 6.1 INTRODUCTION
  • HAP MARKET SIZE, BY TYPE, 2016-2023 (USD MILLION)

THE NANO-SIZED HAP, BECAUSE OF ITS SMALL SIZE, ACTS AS A FILLER REPAIRING THE HOLES AND DEPRESSIONS ON THE ENAMEL SURFACE.

  • Health Services
  • Injectable Delivery
  • North America
  • United States
  • World
  • Comorbidities

Figure ## and Figure ## present the one-year total and one-year diagnosed prevalent cases of AD, respectively.

  • Dermatological Condition
  • Health Services
  • Pathology
  • United States
  • Forecast
  • Depression (14%)
  • Increase in IONM Utilization Rates for Depression and Simple Fusion in US

NORTH AMERICA ##.

  • Health Services
  • Patient Monitoring
  • North America
  • United States
  • Natus Medical Incorporated
  • FACTORS INFLUENCING THE THREAT OF SUBSTITUTES IN THE HEALTHCARE PROVIDERS SECTOR IN JAPAN, 2018
  • FACTORS INFLUENCING THE THREAT OF SUBSTITUTES IN THE HEALTHCARE PROVIDERS SECTOR IN ASIA- PACIFIC, 2018

These types of therapies may help with disorders such as depression and anxiety.

  • Health Services
  • North America
  • Western Europe
  • World
  • Market Size
  • Segmentation by patients

If untreated, hearing loss can lead to dementia and depression among adults.

  • Health Services
  • World
  • Forecast
  • Sonova Holding AG
  • William Demant Holding
  • WITHDRAWAL FROM WORK OR SOCIAL ACTIVITIES
  • 4.4 PROGNOSIS

DEPRESSION IN ALZHEIMER' S DISEASE: HETEROGENEITY AND RELATED ISSUES.

  • Health Services
  • Injectable Delivery
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Comorbidities
  • 4.1 BIBLIOGRAPHY

HIGH PREVALENCE OF ANXIETY AND DEPRESSION IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA.

  • Health Services
  • Japan
  • United States
  • World
  • Forecast